Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery

Circulation

Volumn 93, Issue 3, 1996, Pages 577-584

  Chen, Shi Juan ^a   Li, Huaibin ^a   Durand, Joan ^a   Oparil, Suzanne ^a,b   Chen, Yiu Fai ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

genes; hormones; stenosis

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTERY OCCLUSION; ARTICLE; BALLOON DILATATION; BLOOD VESSEL INJURY; CAROTID ARTERY; CONTROLLED STUDY; FEMALE; GENE ACTIVATION; GONADECTOMY; IMMEDIATE EARLY GENE; MALE; NONHUMAN; NORTHERN BLOTTING; ONCOGENE C MYC; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; VASCULAR DISEASE;

EID: 0030020286     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.3.577     Document Type: Article

References (40)

1. Godsland IF, Wynn V, Crook D, Miller NE. Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions. Am Heart J. 1987;114:1467-1503.
2. Bush TL, Barrett-Connor E. Noncontraceptive estrogen use and cardiovascular disease. Epidemiol Rev. 1985;7:89-104.
3. Knopp RH. The effects of postmenopausal estrogen therapy on the incidence of arteriosclerotic vascular disease. Obstet Gynecol. 1988; 72(suppl 5):23S-30S.
4. Riedel M, Rafflenbeul W, Lichtlen P. Ovarian sex steroids and atherosclerosis. Clin Investig. 1993;71:406-412.
5. Deeley RG, Tam SP, Archer TK. The effects of estrogen on apolipoprotein synthesis. Can J Biochem Cell Biol. 1985;63:882-889.
6. Wagner JD, Clarkson TB, St Clair RW, Schwenke DC, Shivery CA, Adams MR. Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest. 1991;88:1995-2002.
7. Fischer GM, Bashey RI, Rosenbaum H, Lyttle CR. A possible mechanism in arterial wall for mediation of sex difference in atherosclerosis. Exp Mol Pathol. 1985;43:288-296.
8. Alexander JJ, Hoenig M, Graham D, Imbembo AL. The effect of estrogen on low-density lipoprotein binding kinetics in aortic endothelial cells. Surgery. 1989;106:386-391.
9. Rifici VA, Khachadurian AK. The inhibition of low-density lipoprotein oxidation by 17-β estradiol. Metabolism. 1992;41: 1110-1114.
10. Gilligan DM, Quyyumi AA, Cannon RO III. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation. 1994;89:2545-2551.
11. Keaney JF Jr, Shwaery GT, Xu A, Nicolosi RJ, Loscalzo J, Foxall TL, Vita JA. 17β-Estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation. 1994;89:2251-2259.
12. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. 1990;81: 1680-1687.
13. Shan J, Resnick LM, Liu QY, Wu XC, Barbagallo M, Pang PKT. Vascular effects of 17β-estradiol in male Sprague-Dawley rats. Am J Physiol. 1994;266:H967-H973.
14. Chang WC, Nakao J, Orimo H, Murota S. Stimulation of prostacyclin biosynthetic activity by estradiol in rat aortic smooth muscle cells in culture. Biochim Biophys Acta. 1980;619:107-118.
15. Muller DWM, Ellis SG, Topol EJ. Experimental models of coronary artery restenosis. J Am Coll Cardiol. 1992;19:418-432.
16. Chen SJ, Chen YF, Miller DM, Li H, Oparil S. Mithramycin inhibits myointimal proliferation after balloon injury of the rat carotid artery in vivo. Circulation. 1994;90:2468-2473.
17. Legan SJ, Coon GA, Karsch FJ. Role of estrogen as initiator of daily LH surges in the ovariectomized rat. Endocrinology. 1975;96: 50-56.
18. Sommerville EM, Tarttelin MF. Plasma testosterone levels in adults and neonatal female rats bearing testosterone propionate-filled silicone elastomer capsules for varying periods of time. J Endocrinol. 1983;98:365-371.
19. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
20. Kaczmarek L, Hyland JK. Microinjected c-myc as a competence factor. Science. 1985;228:1313-1315.
21. Powell JS, Muller RKM, Baumgartner HR. Suppression of the vascular response to injury: the role of angiotensin-converting enzyme inhibitors. J Am Coll Cardiol. 1991;17(6 suppl B):137B-142B.
22. Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS, Wolfe MS, Clarkson TB. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Arteriosclerosis. 1990; 10:1051-1057.
23. Pick R, Stamler J, Rodbard S, Katz LN. The inhibition of coronary atherosclerosis by estrogens in cholesterol-fed chicks. Circulation. 1951;6:276-280.
24. Cheng LP, Kuwahara M, Jacobsson J, Foegh ML. Inhibition of myointimal hyperplasia and macrophage infiltration by estradiol in aorta allografts. Transplantation. 1991;52:967-972.
25. Rhee CY, Spaet TH, Stemerman MB, Lajam F, Shiang HH, Caruso E, Litwak RS. Estrogen suppression of surgically induced vascular intimai hyperplasia in rabbits. J Lab Clin Med. 1977;90:77-84.
26. Foegh ML, Asotra S, Howell MH, Ramwell PW. Estradiol inhibition of arterial neointimal hyperplasia after balloon injury. J Vasc Surg. 1994;19:722-726.
27. Vargas R, Wroblewska B, Rego A, Hatch J, Ramwell PW. Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol. 1993;109:612-617.
28. Fischer-Dzoga K, Wissler RW, Vesselinovitch D. The effect of estradiol on the proliferation of rabbit aortic medial tissue culture cells induced by hyperlipemic serum. Exp Mol Pathol. 1983;39:355-363.
29. Horwitz KB, Horwitz LD. Canine vascular tissues are targets for androgens, estrogens, progestins and glucocorticoids. J Clin Invest. 1982;69:750-758.
30. Tamaya T, Misao R, Nakagawa M, Itoh T, Wada K, Fujimoto J, Imai A. Estrogen and androgen receptors in aorta of the rabbit and regulation by estrogen and androgen. Res Commun Chem Pathol Pharmacol. 1993;82:3-11.
31. Orimo A, Inoue S, Ikegami A, Hosoi T, Akishita M, Ouchi Y, Muramatsu M, Orimo H. Vascular smooth muscle cells as target for estrogen. Biochem Biophys Res Commun. 1993;195:730-736.
32. Lin AL, Gonzalez R Jr, Carey KD, Shain SA. Estradiol-17β affects estrogen receptor distribution and elevates progesterone receptor content in baboon aorta. Arteriosclerosis. 1986;6:495-504.
33. Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation. 1994;89:1943-1950.
34. Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation. 1994;89:1501-1510.
35. Kam J, Watson JV, Lowe AD, Green SM, Vedeckis W. Regulation of cell cycle duration by c-myc levels. Oncogene. 1989;4:773-787.
36. Schneider MD, Parker TG. Cardiac myocytes as targets for the action of peptide growth factors. Circulation. 1990;81:1443-1456.
37. Polansky D, Thomas S, Snyder R, Eldridge C, Oparil S, Naftilan A, Miller DM. Selective inhibition of c-myc expression prevents smooth muscle proliferation in response to serum. Clin Res. 1990; 38:972A. Abstract.
38. Miano JM, Tota RR, Vlasic N, Danishefsky KJ, Stemerman MB. Early proto-oncogene expression in rat aortic smooth muscle cells following endothelial removal. Am J Pathol. 1990;137:761-765.
39. Bauters C, de Groote P, Adamantidis M, Delcayre C, Hamon M, Lablanche JM, Bertrand ME, Dupuis B, Swynghedauw B. Protooncogene expression in rabbit aorta after wall injury: first marker of the cellular process leading to restenosis after angioplasty? Eur Heart J. 1992;13:556-559.
40. Dubik D, Dembinski TC, Shiu RPC. Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. Cancer Res. 1987;47:6517-6521.